68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT07310355 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07310355
Sponsor: Chengdu StarRay Therapeutics Co., Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Start date: 2025-12-30
Primary completion: 2028-06-30
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.